LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
19.50
+0.25 (1.30%)
At close: Dec 5, 2025, 4:00 PM EST
19.89
+0.39 (2.00%)
After-hours: Dec 5, 2025, 7:34 PM EST
LB Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -18.8 | -63.1 | -6.28 | -14.35 |
| Depreciation & Amortization | 0.32 | 0.09 | 0 | 0 |
| Other Amortization | - | 3.22 | 3.88 | 1.64 |
| Loss (Gain) From Sale of Investments | -0.3 | -0.99 | 0.1 | -0 |
| Stock-Based Compensation | 4.13 | 3.16 | 0.3 | 0.43 |
| Other Operating Activities | -1.14 | 1.26 | -8.79 | 9.46 |
| Change in Accounts Payable | -5.8 | 5.02 | 1.1 | 0.13 |
| Change in Other Net Operating Assets | -1.17 | -1.7 | -2.41 | -0.05 |
| Operating Cash Flow | -22.77 | -53.05 | -12.09 | -2.73 |
| Capital Expenditures | -0.25 | -0.77 | -0.03 | - |
| Investment in Securities | -26.06 | 24 | -27.99 | 0.12 |
| Investing Cash Flow | -26.31 | 23.23 | -28.01 | 0.12 |
| Long-Term Debt Issued | - | - | 0.73 | 25.01 |
| Net Debt Issued (Repaid) | - | - | 0.73 | 25.01 |
| Issuance of Common Stock | 328 | 0.02 | 0 | - |
| Other Financing Activities | -24.27 | -1.71 | -2.05 | -2.95 |
| Financing Cash Flow | 303.73 | 38.32 | 33.68 | 22.96 |
| Net Cash Flow | 254.65 | 8.5 | -6.43 | 20.36 |
| Free Cash Flow | -23.02 | -53.82 | -12.12 | -2.73 |
| Free Cash Flow Per Share | -0.91 | -213.75 | -48.55 | -11.80 |
| Cash Interest Paid | - | - | 1.98 | - |
| Cash Income Tax Paid | 0 | 0 | 0 | 0 |
| Levered Free Cash Flow | - | -28.34 | -6.09 | - |
| Unlevered Free Cash Flow | - | -28.34 | -6.96 | - |
| Change in Working Capital | -6.97 | 3.31 | -1.31 | 0.09 |
Source: S&P Capital IQ. Standard template.
Financial Sources.